Jaguar Health Statistics
Total Valuation
Jaguar Health has a market cap or net worth of $4.62 million. The enterprise value is $33.05 million.
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025, before market open.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Jaguar Health has 674,043 shares outstanding. The number of shares has increased by 1,809.95% in one year.
| Current Share Class | 674,043 |
| Shares Outstanding | 674,043 |
| Shares Change (YoY) | +1,809.95% |
| Shares Change (QoQ) | +27.07% |
| Owned by Insiders (%) | 9.74% |
| Owned by Institutions (%) | 6.37% |
| Float | 608,396 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.15 |
| Forward PS | 0.28 |
| PB Ratio | 0.44 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 4.07.
| Current Ratio | 1.63 |
| Quick Ratio | 0.49 |
| Debt / Equity | 4.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -133.47 |
Financial Efficiency
Return on equity (ROE) is -565.74% and return on invested capital (ROIC) is -44.05%.
| Return on Equity (ROE) | -565.74% |
| Return on Assets (ROA) | -36.99% |
| Return on Invested Capital (ROIC) | -44.05% |
| Return on Capital Employed (ROCE) | -91.43% |
| Revenue Per Employee | $238,551 |
| Profits Per Employee | -$785,551 |
| Employee Count | 49 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 0.20 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.46% in the last 52 weeks. The beta is 1.11, so Jaguar Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | -97.46% |
| 50-Day Moving Average | 10.92 |
| 200-Day Moving Average | 27.17 |
| Relative Strength Index (RSI) | 48.55 |
| Average Volume (20 Days) | 66,560 |
Short Selling Information
The latest short interest is 51,062, so 7.58% of the outstanding shares have been sold short.
| Short Interest | 51,062 |
| Short Previous Month | 891,219 |
| Short % of Shares Out | 7.58% |
| Short % of Float | 8.39% |
| Short Ratio (days to cover) | 1.44 |
Income Statement
In the last 12 months, Jaguar Health had revenue of $11.69 million and -$38.49 million in losses. Loss per share was -$130.69.
| Revenue | 11.69M |
| Gross Profit | 9.73M |
| Operating Income | -30.83M |
| Pretax Income | -38.32M |
| Net Income | -38.49M |
| EBITDA | -28.93M |
| EBIT | -30.83M |
| Loss Per Share | -$130.69 |
Full Income StatementBalance Sheet
The company has $8.00 million in cash and $36.53 million in debt, giving a net cash position of -$28.52 million or -$42.32 per share.
| Cash & Cash Equivalents | 8.00M |
| Total Debt | 36.53M |
| Net Cash | -28.52M |
| Net Cash Per Share | -$42.32 |
| Equity (Book Value) | 8.98M |
| Book Value Per Share | 13.79 |
| Working Capital | 12.49M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$29.38 million and capital expenditures -$16,000, giving a free cash flow of -$29.40 million.
| Operating Cash Flow | -29.38M |
| Capital Expenditures | -16,000 |
| Free Cash Flow | -29.40M |
| FCF Per Share | -$43.62 |
Full Cash Flow StatementMargins
| Gross Margin | 83.27% |
| Operating Margin | -263.76% |
| Pretax Margin | -335.79% |
| Profit Margin | n/a |
| EBITDA Margin | -247.51% |
| EBIT Margin | -263.76% |
| FCF Margin | n/a |